Women with pre-eclampsia during pregnancy have a five-fold increased risk of end stage kidney disease (ESKD) later in life compared to women who don’t develop pre-eclampsia during pregnancy, according to a new study. Professor Louise Kenny from the University of Liverpool is one of the co-authors of the study, which is published in PLOS Medicine and also involved researchers at University…
For over 20 years, a team of researchers at Lund University has worked on developing a drug against preeclampsia – a serious disorder which annually affects around 9 million pregnant women worldwide and is one of the main causes of death in both mothers and unborn babies. Now the researchers have published a study in the journal Scientific Reports that opens up opportunities for further…
A team of specialists at UPMC Magee-Womens Hospital and UPMC Children's Hospital of Pittsburgh have performed UPMC's first in-utero surgery to close an open neural tube defect in a baby months before her birth.
At ECR 2019, Jean-Luc Budillon, President & COO of Hitachi Medical Systems Europe, introduces the newest members of the Arietta Family. The Arietta 50, Arietta 50LE and Arietta 65 ultrasound systems are perfectly equipped for shared service in diagnostic imaging. From OB/Gyn to radiology, the 3 new Arietta systems complete Hitachi's portfolio of ultrasound solutions.
Younger women who have recently had a child may have a higher risk of breast cancer than their peers of the same age who do not have children, according to a large-scale analysis co-led by a University of North Carolina Lineberger Comprehensive Cancer Center researcher. The findings, published in the Annals of Internal Medicine, may seem contrary to conventional wisdom that childbirth is…
Hitachi’s Fusion imaging combining MRI and Real-time Virtual Sonography (RVS) showing a cervix lesion with color Doppler Fusion imaging techniques are being trialled to help advance the diagnosis of cervical cancer and endometrial cancer.
Tracy Accardi, Hologic’s Vice President (Global R&D), spoke of the importance of innovation, tomosynthesis, artificial intelligence/deep learning and open dialogue with the radiology community. Hologic addresses a broad spectrum of gynaecological, perinatal, aesthetic, skeletal and breast women’s health issues. To enhance this approach, Accardi, explained the importance of working closely…
‘In prenatal diagnostics, particularly in the first trimester, ultrasound continues to be the modality of choice when looking for malformations,’ says Professor Markus Hoopmann, deputy director of prenatal medicine and gynaecological ultrasound at the Women’s Health Clinic in Tübingen University Hospital. This case for ultrasound is significant because today fetal DNA that circulates in…
Philips TrueVue, GlassVue, aReveal A.I. and TouchVue improve workflow and diagnostic confidence, enhancing the connection between clinicians and their patients.
Today, many congenital heart defects can be diagnosed in the unborn child – and even treated in utero. Monique Haak (46), gynaecologist-perinatologist and fetal surgeon at Leids University Medical Center (LUMC) in Leiden, The Netherlands, is an expert in the diagnosis and surgery of fetal heart defects.
The Acuson NX3* and Acuson NX3 Elite*, two new ultrasound systems from Siemens Healthcare, are on show at this year’s Medica Trade Fair. ‘Both mid-range systems offer a simple, intuitive interface combined with innovative imaging solutions for examinations primarily in general medicine, obstetrics/gynaecology, paediatrics and neurology,’ the manufacturer reports.
The new Philips Avalon CL’s cable-less design enables mothers to move more freely during labour and uses Smart Pulse technology to automatically detect the coincidence between maternal pulse and foetal heart rate, even for twins and triplets.
The survival of premature newborns in England is 30% higher in specialist units treating large numbers of neonates, reveals an analysis of national data published in the online journal BMJ Open.
HRH the Duke of Kent, President of King Edward VII’s Hospital, today officially re-opened the expanded outpatients unit at Emmanuel Kaye House in London. The Hospital’s newly refurbished unit has doubled in size and will now offer eleven consulting rooms to accompany the growing number of patients
New Assay Is First to Standardize to World Health Organization’s 5th International Standard for Chorionic Gonadotropin
Down’s syndrome (also referred to as trisomy 21) is a genetic disorder caused by the presence of all or part of an extra copy of chromosome 21 in a person’s DNA.
Sanofi and the Curie Institute, through its Curie-Cancer partnership under the Institut Carnot label, today announce the establishment of a three-year research collaboration to identify new therapeutic targets for the development of treatments for ovarian cancer.
Hedvig Hricak, Chair of the Radiology Department at the Memorial Sloan-Kettering Cancer Center, New York, USA, describes emerging applications and potential trends in gynaecological cancer treatment described at the 15th International Symposium Crossing Barriers
Modern imaging techniques greatly enhance the treatment selection
GE Healthcare yesterday announced the availability of the Giraffe® Stand-Alone Infant Resuscitation (STAR) System, which integrates critical capabilities to enhance effective resuscitation of newborns.
Accuvix A30 produces impressive results in the prenatal diagnostics arena and Samsung could become a serious contender in the ultrasound champions’ league.
‘The egg timer test’ is widely used to help determine how long a woman can expect to remain fertile. Lately it has shown even greater potential for clinical use as a biomarker for ovarian viability.
Suspicion of venous thromboembolism (VTE) in a pregnant patient will quickly bring a radiologist to a choice, where the next step holds potentially significant consequences for both the mother and unborn child.
In 2012, Chicago’s Children’s Memorial Hospital will be in transition, with a change of name as well as location, when its top class technology, physicians, scientists, staff and patients transfer to a new state-of-the-art complex three miles away.
‘As we become more successful in the early detection and treatment of breast cancer, we tend to trivialise it. Yet one in 9 women still get breast cancer. Half of them become depressed, their partners don’t know how to react and their families are in disarray. We need to stop trivialising breast cancer. It kills women.’ So says Dr Fabienne Liebens, Head of the Saint-Pierre Hospital’s…